Home › Trial NCT06793241
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
- Trial IDNCT06793241
- StatusRecruiting
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorZhejiang University
- Enrollment15
- Start date2025-01-31
- ConditionsB-cell Acute Lymphoblastic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.